MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-06-0000759
Shreeyansh Pharma Private Limited
Shreeyansh Pharma Private Limited - pharma in Medak, Telangana, India. Directors, charges & compliance details.
Revenue · FY 2024
₹1 Lakh
Latest filing
Net profit · FY 2024
₹94,250
Net margin 94%
EBITDA · FY 2024
₹94,250
EBITDA margin 94%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
GST registrations
1
None active
About Shreeyansh Pharma Private Limited
Data last updated:
Shreeyansh Pharma Private Limited is a private limited company based in Medak, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC142582. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sudhakar Babu Talluri and Ramakrishna Prasad Mandava.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 43A Ip Kucharam Toopran (Mandal), Medak, Telangana, India – 502336.
As per the financials filed for FY 2024, the company reported a revenue of ₹1 Lakh. For the same year it recorded a net profit of ₹94,250 (net margin 94%) and EBITDA of ₹94,250 (EBITDA margin 94%).
Shreeyansh Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-06-0000759).
Company details
CIN U24290TG2020PTC142582
Registration Number 142582
Incorporation Date 06 August 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-TS-06-0000759
Recognitions & Rankings of Shreeyansh Pharma
Contact details
Shreeyansh Pharma Private Limited's registered office is in Medak, Telangana.
- Registered AddressPlot No 43A Ip Kucharam Toopran (Mandal), Medak, Telangana, India – 502336
- IndustryPharma, API Manufacturers
Comprehensive company report
Shreeyansh Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Shreeyansh Pharma Private Limited
FY 2024 filings availableShreeyansh Pharma Private Limited reported revenue of ₹1 Lakh for FY 2024.
Revenue · FY 2024
₹1 Lakh
Net profit · FY 2024
₹94,250 margin 94%
EBITDA · FY 2024
₹94,250 margin 94%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹94,250 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹94,250 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 94% | |||
| Net Profit Margin | 94% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Shreeyansh Pharma Private Limited, buy the company report.
Board of directors of Shreeyansh Pharma Private Limited
Shreeyansh Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhakar Babu Talluri | Director | 06 Aug 2020 | 6 Years 3 Months | Current |
| Ramakrishna Prasad Mandava Also directs: Aarvensa Pharmachem LLP | Director | 12 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Shreeyansh Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cyklo Pharma Chem Pvt Ltd | ₹1.79 Lakh (FY 2024) | -67.0% | Maharastra, Maharashtra, India | |||
| Hifil Chemicals Private Limited | ₹1.65 Lakh (FY 2025) | 1.0% | Thane, Maharashtra, India | |||
| Kaanthi Laboratories Private Limited | ₹1.6 Lakh (FY 2024) | 1.0% | Hyderabad, Telangana, India | |||
| Kobo Biotech Limited | ₹1.52 Lakh (FY 2023) | -8.0% | Hyderabad, Telangana, India | |||
| Kirthy Pharmachem Private Limited | ₹1.38 Lakh (FY 2024) | Hyderabad, Telangana, India | ||||
| Shreeyansh Pharma Private Limitedthis company | ₹1 Lakh (FY 2024) | ₹94,250 | 94% | Medak, Telangana, India | ||
| Loroly Healthcare Private Limited | ₹95,689 (FY 2025) | -98.0% | Thane, Maharashtra, India | |||
| Gencor Cultech India Private Limited | ₹92,572 (FY 2021) | Chennai, Tamil Nadu, India | ||||
| Vivin Laboratories Private Limited | ₹89,760 (FY 2021) | -56.0% | Jubilee Hills, Hyderabad-33, Telangana, India | |||
| Ysk Laboratories Private Limited | ₹86,563 (FY 2025) | Mumbai, Maharashtra, India | ||||
| Eastland Exports Company Private Limited | ₹78,000 (FY 2017) | 20.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Shreeyansh Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shreeyansh Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shreeyansh Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shreeyansh Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Shreeyansh Pharma Private Limited, buy the company report.
Recent activity
Shreeyansh Pharma Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Kotte Praveena ceased to be Director on 16 Aug 2021.
AGM
Shreeyansh Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Shreeyansh Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Kotte Praveena ceased to be Director.
Appointed
Ramakrishna Prasad Mandava was appointed as Director.
Appointed
Sudhakar Babu Talluri was appointed as Director.
Incorporation
06 Aug 2020
Shreeyansh Pharma Private Limited was registered on 06 Aug 2020 with Roc Hyderabad & aged 6 years 3 months as per MCA records.
Frequently asked questions
Shreeyansh Pharma is an active private limited company based in Medak, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 August 2020 (6+ years old) and is registered under CIN U24290TG2020PTC142582.
Shreeyansh Pharma has 2 current directors:
- Sudhakar Babu Talluri - Director
- Ramakrishna Prasad Mandava - Director
The latest financial statements of Shreeyansh Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
No. Shreeyansh Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Shreeyansh Pharma is U24290TG2020PTC142582. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shreeyansh Pharma was incorporated on 06 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Shreeyansh Pharma by revenue are Cyklo Pharma Chem Pvt Ltd, Hifil Chemicals Private Limited, Kaanthi Laboratories Private Limited, Kobo Biotech Limited, Kirthy Pharmachem Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Kotte Praveena ceased to be Director on 16 Aug 2021. Ramakrishna Prasad Mandava was appointed as Director on 12 Aug 2020. Sudhakar Babu Talluri was appointed as Director on 06 Aug 2020.
Yes, Shreeyansh Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-06-0000759).
The registered office of Shreeyansh Pharma is at Plot No 43A Ip Kucharam Toopran Mandal, Medak, Telangana, India – 502336.
Shreeyansh Pharma operates in the pharma industry, in the api manufacturers segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages